                         SEQUENCE LISTING

<110>  ETH Zurich
 
<120>  Screening assay for metabolic disease therapeuticals

<130>  24972 WO

<150>  EP08020866.3
<151>  2008-12-02

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  222
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Leu Trp Leu Leu Phe Phe Leu Val Thr Ala Ile His Ala Glu Leu 
1               5                   10                  15      


Cys Gln Pro Gly Ala Glu Asn Ala Phe Lys Val Arg Leu Ser Ile Arg 
            20                  25                  30          


Thr Ala Leu Gly Asp Lys Ala Tyr Ala Trp Asp Thr Asn Glu Glu Tyr 
        35                  40                  45              


Leu Phe Lys Ala Met Val Ala Phe Ser Met Arg Lys Val Pro Asn Arg 
    50                  55                  60                  


Glu Ala Thr Glu Ile Ser His Val Leu Leu Cys Asn Val Thr Gln Arg 
65                  70                  75                  80  


Val Ser Phe Trp Phe Val Val Thr Asp Pro Ser Lys Asn His Thr Leu 
                85                  90                  95      


Pro Ala Val Glu Val Gln Ser Ala Ile Arg Met Asn Lys Asn Arg Ile 
            100                 105                 110         


Asn Asn Ala Phe Phe Leu Asn Asp Gln Thr Leu Glu Phe Leu Lys Ile 
        115                 120                 125             


Pro Ser Thr Leu Ala Pro Pro Met Asp Pro Ser Val Pro Ile Trp Ile 
    130                 135                 140                 


Ile Ile Phe Gly Val Ile Phe Cys Ile Ile Ile Val Ala Ile Ala Leu 
145                 150                 155                 160 


Leu Ile Leu Ser Gly Ile Trp Gln Arg Arg Arg Lys Asn Lys Glu Pro 
                165                 170                 175     


Ser Glu Val Asp Asp Ala Glu Asp Lys Cys Glu Asn Met Ile Thr Ile 
            180                 185                 190         


Glu Asn Gly Ile Pro Ser Asp Pro Leu Asp Met Lys Gly Gly His Ile 
        195                 200                 205             


Asn Asp Ala Phe Met Thr Glu Asp Glu Arg Leu Thr Pro Leu 
    210                 215                 220         


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TMEM27 fragment

<400>  2

Asn Arg Ile Asn Asn Ala Phe Phe Leu Asn Asp Gln Thr Leu Glu Phe 
1               5                   10                  15      


Leu Lys 
        


<210>  3
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  3

Gly Asn Ser Ala Asp Ile Gln His Ser Gly Gly Arg Ser Ser Leu Glu 
1               5                   10                  15      


Gly Pro Arg Phe Glu Gly Lys 
            20              


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  4

Ile Asn Ser Ala Phe Phe Leu Asp Asp His Thr Leu Glu Phe 
1               5                   10                  


<210>  5
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  5

Arg Met Asn Lys Arg Ile Asn Asn Ala Phe Phe Leu Asn Asp Gln Thr 
1               5                   10                  15      


Leu Glu Phe Leu Lys Ile Pro Ser Leu Ala Pro Pro Met Asp Pro Ser 
            20                  25                  30          


Val Pro Ile 
        35  


<210>  6
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  6

Arg Lys Asn Arg Asn Arg Ile Asn Ser Ala Phe Phe Leu Asp Asp His 
1               5                   10                  15      


Thr Leu Glu Phe Leu Lys Ile Pro Ser Thr Leu Ala Pro Pro Met Glu 
            20                  25                  30          


Pro Ser Val Pro Val 
        35          


<210>  7
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  7

Arg Met Asn Arg Asn Arg Ile Asn Asn Ala Phe Phe Leu Asn Asp Gln 
1               5                   10                  15      


Thr Leu Glu Phe Leu Arg Ile Pro Ser Thr Leu Ala Pro Pro Thr Asp 
            20                  25                  30          


Pro Ser Val Pro Ile 
        35          


<210>  8
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  8

Arg Asn Glu Arg Asn Arg Ile Asn Ser Ala Phe Leu Leu Asp Asp Lys 
1               5                   10                  15      


Thr Leu Glu Phe Val Gln Ile Pro Pro Thr Leu Ala Pro Ala Thr Gln 
            20                  25                  30          


Thr Ser Ser Ser Ser 
        35          


<210>  9
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  9

Arg Gln Ser Lys His Arg Ile Asn Asn Ala Phe Leu Leu Ser Asp Met 
1               5                   10                  15      


Thr Leu Glu Phe Val Gly Val Pro Pro Thr Leu Ala Val Pro Ile Gln 
            20                  25                  30          


Tyr Asn Thr Pro Pro 
        35          


<210>  10
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  10

Pro Ala Glu Arg His Ala Asp Gly Leu Ala Leu Ala Glu Pro Ala Leu 
1               5                   10                  15      


Ala Ser Pro Ala Gly Ala Ala Asn Phe Leu Ala Met Val Asp 
            20                  25                  30  


<210>  11
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  11

Ser Glu Val Leu Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val 
1               5                   10                  15      


His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys 
            20                  25                  30          


<210>  12
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  12

Ser Glu Val Lys Met Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu 
1               5                   10                  15      


Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn 
            20                  25                  30          


Lys 
    


<210>  13
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  13

Leu Glu Val Val His Asn Thr Leu Ser Phe Gln Thr Leu Arg Thr Thr 
1               5                   10                  15      


Val Lys Glu Ala Ser Ser Thr Phe Ser 
            20                  25  


<210>  14
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  14

Arg Met Asn Lys Asn Arg Ile Asn Asn Ala Phe Phe Leu Asn Asp Gln 
1               5                   10                  15      


Thr Leu Glu Phe Leu Lys Ile Pro Ser Thr Leu Ala Pro Pro 
            20                  25                  30  


<210>  15
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  15

Arg Lys Asn Arg Asn Arg Ile Asn Ser Ala Phe Phe Asp Asp His Thr 
1               5                   10                  15      


Leu Glu Phe Leu Lys Ile Pro Ser Thr Leu Ala Pro Pro 
            20                  25                  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  16

Asn Asp Gln Thr Leu Glu Phe Leu Lys 
1               5                   


<210>  17
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  17

Phe Leu Asn Asp Gln Thr Leu Glu Phe Leu Lys 
1               5                   10      


